Affiliation:
1. Bennett University, India
2. MIT World Peace University, India
3. Department of Electronics and Communication Engineering, Bharat Institute of Engineering and Technology, Hyderabad, India
4. School of Computer Science Engineering and Technology, Bennett University, India
Abstract
This manuscript explores the transformative impact of computational drug discovery in pharmaceutical research, emphasizing the integration of algorithms, simulations, and modeling to expedite the development of therapeutic agents. It highlights the multidisciplinary nature of this approach, leveraging insights from computer science, chemistry, biology, and pharmacology. The narrative underscores the crucial role of artificial intelligence (AI) and machine learning (ML) technologies in enhancing the efficiency and precision of drug discovery. These technologies enable the analysis of complex biological data, facilitating the identification of novel drug targets and the prediction of drug efficacies and side effects with unprecedented accuracy. Additionally, the chapter discusses the significance of computational methodologies in improving the speed, cost-effectiveness, and success rates of developing new drugs. Through high-throughput screening and detailed molecular analysis, these methods allow for the rapid identification of promising compounds and offer insights into disease mechanisms, paving the way for targeted therapeutic interventions. This overview aims to showcase the critical role of computational drug discovery in advancing personalized, effective, and patient-centered treatments, marking a significant shift towards more innovative and efficient drug development processes.
Reference49 articles.
1. Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents
2. High-Throughput Screening: today’s biochemical and cell-based approaches
3. Bovdilova, A. (2020). Molecular adaptations and post-translational regulation of C4-NADP-malic enzyme [Doctoral dissertation, Dissertation, Düsseldorf, Heinrich-Heine-Universität, 2019].
4. CaseD. A.AktulgaH. M.BelfonK.Ben-ShalomI.BrozellS. R.CeruttiD. S.KollmanP. A. (2021). Amber 2021. University of California.
5. Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012). Structure-based virtual screening for drug discovery: a problem-centric review. The AAPS Journal, 14(1), 133-141.